托尔瓦普坦与肝硬化患者的低血其他干预措施相比
K N Anila1, Nair S Saraswathy1, Zubair U Mohamed2
1Department of GI Surgery and Solid Organ Transplantation, Amrita Institute of Medical Sciences & Research Centre, Kochi, India.
The Cochrane database of systematic reviews
|November 10, 2025
概括
这次审查将评估托尔瓦普坦用于治疗肝硬化患者的低血. 它将托尔瓦普坦与标准治疗,安慰剂或其他瓦普坦进行比较,以确定益处和危害.
科学领域:
- 胃肠病学和肝病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床药理学 临床药理学
背景情况:
- 低血是肝硬化患者的常见并发症.
- 目前对肝硬化中低血的治疗有局限性.
- 托尔瓦普坦是一种血管压素V2受体对手,具有管理液体和电解质平衡的潜力.
研究的目的:
- 评估tolvaptan在治疗肝硬化患者的低血的疗效和安全性.
- 为了比较tolvaptan与标准的医疗管理,安慰剂和其他血管压素受体对抗剂 (vaptans).
主要方法:
- 这是柯克伦审查的协议.
- 对随机对照试验进行系统的文献搜索.
- 对相关数据的元分析,以综合有关益处和危害的证据.
主要成果:
- 目前正在合成有关托尔瓦普坦的益处和危害的数据.
- 具体的结果将包括血清水平的变化,不良事件和死亡率.
结论:
- 这些发现将为临床实践提供有关托尔瓦普坦在患有低血症的肝硬化患者的使用的信息.
- 证据将指导治疗决策,并突出未来研究领域.
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K
Heart Failure Drugs: Diuretics
779
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
779
Antihypertensive Drugs: Action of Diuretics
2.2K
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.2K
Heart Failure VI: Adjunct Therapies
243
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
243
Hemodialysis III: Nursing Management
704
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
704
Acute Kidney Injury VI: Nursing Management
373
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
373


